HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intestinal transplantation in children: the first successful Italian series.

Abstract
The preliminary experience of the first Italian program of pediatric intestinal transplantation is presented herein. A multidisciplinary group with broad experience in pediatric solid organ transplantation started the program. Nine children with complications of chronic intestinal failure were listed for transplantation. One child died on the waiting list; one received an isolated liver transplantation; three isolated intestinal; three multivisceral; and one, a combined liver/intestine transplantation. There was no in-hospital mortality, and all children were weaned from parenteral nutrition. The recipient of the multivisceral graft died after 14 months for unknown causes. All other recipients are alive after a median follow-up of 13 months. Patient and graft actuarial survivals for recipients of intestinal grafts were 100% at 1 year and 75% at 2 years.
AuthorsM Colledan, P Stroppa, M Bravi, V Casotti, A Lucianetti, D Pinelli, M Zambelli, M Guizzetti, V Corno, A Aluffi, V Sonzogni, A Sonzogni, L D'Antiga, D Codazzi
JournalTransplantation proceedings (Transplant Proc) Vol. 42 Issue 4 Pg. 1251-2 (May 2010) ISSN: 1873-2623 [Electronic] United States
PMID20534273 (Publication Type: Journal Article)
CopyrightCopyright (c) 2010 Elsevier Inc. All rights reserved.
Topics
  • Child
  • Child, Preschool
  • Cytomegalovirus Infections (surgery)
  • Graft Survival
  • Humans
  • Infant
  • Intestinal Atresia (surgery)
  • Intestinal Pseudo-Obstruction (surgery)
  • Intestinal Volvulus (surgery)
  • Intestines (transplantation)
  • Italy
  • Liver Transplantation
  • Short Bowel Syndrome (surgery)
  • Survival Rate
  • Survivors
  • Viscera (transplantation)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: